The review arrives at a politically charged moment. The authors explicitly note that rapid policy shifts in several jurisdictions have favored treatment-focused approaches to addressing homelessness, often framing addiction treatment as a gateway to housing. Against that backdrop, the team set out to determine what the published evidence actually says about the key components and outcomes of housing-based support models. Their answer, drawn from more than 13,000 screened records, is nuanced but firm: the strongest and most consistent evidence favors low-barrier Housing First models, while evidence for treatment-first models remains more limited and heterogeneous.

Methodologically, the review was designed for speed without sacrificing rigor. The researchers searched five major databases — CINAHL, Embase, Medline, APA PsycInfo, and Web of Science — for peer-reviewed studies published between January 1, 2000 and April 30, 2025. After screening 13,393 records, they included 57 studies: eight randomized controlled trials, thirty quasi-experimental studies, six qualitative studies, five mixed-methods studies, and eight other designs. Study quality was appraised using Joanna Briggs Institute tools, and the team extracted data on intervention characteristics, model features, comparison conditions, and outcomes spanning housing stability, substance use, mental health, and service utilization. That breadth of study designs, from gold-standard randomized trials to real-world quasi-experiments, strengthens the ecological validity of the findings while also revealing where the evidence base thins out.

From this body of work, four distinct program types emerged. Scattered-site models place participants in independent apartments dispersed across a community, with support services delivered where people live. Single-site models concentrate housing and on-site services within one building, offering concentrated support but sometimes recreating institutional environments. Transitional housing provides time-limited accommodation intended as a bridge toward permanent housing. Finally, outreach support-to-housing programs begin with street-level engagement and gradually connect individuals to housing. Each architecture carries different assumptions about what people experiencing homelessness need first — and each produces different patterns of outcomes in the literature.

On the headline question of housing stability, the verdict was unambiguous. Housing First models consistently improved housing stability compared with treatment-first, linear treatment-contingent models, or treatment-as-usual conditions. This finding held across randomized trials and observational studies alike, reinforcing what has become a robust international evidence pattern: when the immediate goal is ending homelessness, removing preconditions works. The mechanism is conceptually straightforward. Requiring people to demonstrate sobriety or complete treatment before accessing housing creates a barrier that many with active substance use disorders cannot clear, leaving them cycling through shelters, hospitals, and the street. Housing First inverts that sequence, treating stable housing as the platform from which health improvements become possible.

The picture grows more complicated when the review turns to substance use outcomes. Effects of Housing First on substance use were heterogeneous across studies, with alcohol-related outcomes improving more consistently than illicit drug use. Some trials found meaningful reductions in alcohol consumption and alcohol-related harms among participants in scattered-site Housing First, while effects on illicit drug use varied widely, with some studies showing no significant differences compared with control conditions. This heterogeneity matters for policy. It suggests that housing alone, while transformative for stability, does not automatically resolve the full spectrum of substance use health needs — particularly for stimulant and opioid use, where the evidence for spontaneous improvement in the absence of integrated treatment is weakest.

Mental health outcomes followed a similarly mixed pattern. Some studies reported no differences between Housing First and comparison conditions on measures of psychiatric symptoms, while others documented improvements in psychological distress. The reviewers caution against reading these mixed results as evidence of failure. Mental health trajectories among this population are shaped by many factors beyond housing, including trauma history, physical health, social connection, and access to psychiatric care. What the data do support is that Housing First does not worsen mental health outcomes — a persistent concern among critics — and in several studies actively reduces distress, all while delivering far superior housing outcomes.

Beyond housing and behavioral health, the review examined acute healthcare utilization and costs. Evidence for reductions in psychiatric hospitalization and overall costs was described as promising but less definitive than the housing stability findings. Several studies suggested that Housing First participants spend fewer days in hospitals and emergency departments, generating offsets that partially or fully compensate for the cost of housing and support services. However, the reviewers found this evidence less consistent across studies, likely reflecting differences in health system contexts, measurement approaches, and follow-up durations. For policymakers weighing fiscal arguments, the review suggests the cost case is plausible but not yet ironclad — an area where longer-term, more rigorous economic evaluations are needed.

The authors’ conclusions translate directly into policy recommendations. They call for scaling up low-barrier Housing First programs while integrating expanded voluntary substance use treatment, mental health care, harm reduction services, and wraparound supports within housing. The emphasis on voluntariness is significant: the evidence does not support coercive treatment mandates as a condition of housing, but it does support making comprehensive, choice-based services readily available to tenants who want them. The four program types identified in the review offer a menu rather than a single prescription — scattered-site models may suit people seeking independence, while single-site and transitional models may serve others — but the common thread is that housing comes first, not last.

The review also candidly maps the gaps that remain. While some treatment-first models reported positive outcomes, the evidence base for them was more limited and heterogeneous than for Housing First, making head-to-head comparisons difficult. The authors highlight the need for further comparative research and, critically, more robust longer-term studies to identify which specific program components best support substance use health among this high-needs population. As jurisdictions worldwide grapple with visible homelessness crises and intensifying debates over housing versus treatment paradigms, this review offers a rare commodity: a rigorously synthesized evidence base. Its message is neither that housing solves everything nor that treatment is irrelevant, but that the sequence matters — and the science says house people first, then wrap every effective service around them.

Subject of Research: Housing-based support models for adults experiencing homelessness with substance use and mental health needs

Article Title: Housing-based support models for individuals experiencing homelessness, substance use and mental health needs: a rapid review

Article References: Somefun, O. D., Kerman, N., Corace, K., Taha, S., Buckley, L., & Stergiopoulos, V. (2026). Housing-based support models for individuals experiencing homelessness, substance use and mental health needs: a rapid review. Addiction Science & Clinical Practice. https://doi.org/10.1186/s13722-026-00716-9

Image Credits: AI Generated

DOI: 10.1186/s13722-026-00716-9

Keywords: homelessness, Housing First, substance use, mental health, harm reduction, treatment-first models, housing stability, rapid review, addiction science, psychiatric hospitalization, supportive housing, public health policy

The research team, led by Vedant Tapiavala of Dartmouth College together with collaborators at Massachusetts General Hospital, Dartmouth’s Thayer School of Engineering, Indiana University, the Geisel School of Medicine, and The Bridge in New York City, conducted a secondary analysis of three focus groups held across three supportive housing facilities in New York City. Rather than surveying attitudes with questionnaires, the investigators collected qualitative data, transcribed the discussions, and analyzed them using the RADaR technique, a rapid and rigorous qualitative data analysis method developed for applied research. The approach allows researchers to move quickly from raw transcripts to structured themes while preserving the nuance of what participants actually said, an important consideration when the subject matter touches on trust, vulnerability, and lived experience.

The findings reveal a population that is neither naively enthusiastic nor reflexively hostile toward AI. Participants expressed strong concerns about data privacy and the potential misuse of their information, worries that are amplified for people whose psychiatric histories carry heavy social stigma. At the same time, they recognized real potential in AI tools to support medication reminders, mental health maintenance, and daily functioning. This duality, hope shadowed by caution, runs through the entire study and complicates the simple narratives that often dominate public discussion of chatbots and mental health. For this community, the question is not whether AI companions should exist, but under what conditions they can be trusted.

Trust, the study found, is not a fixed trait that users either bring to or withhold from a system. Instead, it is something that emerges from design choices. Participants reported that their confidence in AI increased when tools were personalized, human-centered, and co-developed with people who understand the lived experience of serious mental illness. That last condition may be the most consequential. A chatbot designed without input from people who have navigated psychosis, mania, or severe depression may miss the signals that matter most, or worse, respond in ways that feel dismissive or unsafe. Co-design, in which end users participate as partners rather than test subjects, emerged as a key factor shaping perceived trustworthiness.

The technical implications of this are significant. Modern conversational AI systems, particularly those built on large language models, are trained on broad datasets that reflect general human communication, not the specific communication patterns, needs, and sensitivities of people with serious mental illness. Personalization in this context means more than remembering a user’s name. It involves calibrating tone, anticipating cognitive and emotional states, respecting boundaries around sensitive topics, and integrating gracefully with clinical care teams. Participants in the study effectively described a set of design requirements that developers of mental health AI would do well to treat as specifications rather than suggestions.

Yet the study also documents a darker set of worries that the participants themselves raised: the fear of losing critical thinking and becoming overreliant on AI companions. This concern is especially poignant for a population where autonomy and self-efficacy are hard-won achievements. An AI that is always available, always agreeable, and always attentive could, in principle, substitute for human connection rather than supplement it. The researchers note that it is essential these technologies lessen, rather than deepen, feelings of loneliness, a distinction that sounds subtle but carries enormous weight for the design and deployment of companion AI in mental health care.

These concerns do not arise in a vacuum. The study’s reference list situates the work within a rapidly growing literature on the mental health risks of large language model chatbots, including recent scoping reviews on chatbot-related harms, analyses of AI-associated delusions and mechanisms of delusion co-creation, and debates in leading psychiatry journals about whether generative AI chatbots might increase psychosis risk. For people with schizophrenia spectrum disorders in particular, the possibility that an AI companion could reinforce distorted thinking is a clinical question of the first order. The study’s participants, by voicing their own concerns about overreliance, demonstrated a sophisticated awareness of these risks that contradicts stereotypes about people with serious mental illness being unable to engage critically with technology.

At the same time, the broader research landscape suggests why AI companions hold such appeal. Loneliness and social isolation are widespread among adults in the United States and are especially pronounced among people with serious mental illness, who face stigma, social withdrawal, and reduced lifespans compared with the general population. Some studies have even found that third-party evaluators perceive AI responses as more compassionate than those of expert humans, and systematic reviews of chatbots versus human healthcare professionals have examined empathy in patient care with mixed but intriguing results. Against that backdrop, a companion that offers unconditional availability and a consistent, nonjudgmental presence has an obvious emotional pull, particularly during the nights and weekends when human support is scarce.

The study’s methodology also deserves attention for what it models. By recruiting participants through supportive housing facilities and partnering with community organizations, the research team reached a population that digital health studies frequently overlook. People with serious mental illness have historically been excluded from technology design processes, sometimes on the assumption that they cannot use or evaluate complex tools. Earlier qualitative work on how patients with schizophrenia use the internet, and international consensus efforts on digital mental health for severe mental illness, have pushed back against that exclusion. This study extends that tradition by treating participants as experts in their own lives, capable of articulating precisely what would make an AI companion feel safe, useful, and trustworthy.

The path forward, the authors suggest, lies in using these lived-experience insights to guide the development of AI tools for people with serious mental illnesses. That means building privacy protections that address the specific fears participants raised, designing personalization that respects clinical complexity, involving peer specialists and people with lived experience throughout the development cycle, and building in safeguards against overreliance. It also means honest acknowledgment of the tensions involved: the same system that tells a lonely person someone cares can become a substitute for the human relationships that recovery ultimately depends on. As AI reshapes healthcare through clinical decision support, communication tools, and patient monitoring, this study offers a reminder that the people most affected by these technologies have clear views about how they should work, and that listening to them is not just ethical but essential to building systems that actually help.

Subject of Research: Perspectives of people with serious mental illness on artificial intelligence-based companions in mental health care

Article Title: Perspectives of People with Serious Mental Illness on Artificial Intelligence-Based Companions: “If no one told you I love you today, you have someone that cares for you.”

Article References: Tapiavala, V., Chilakapati, S. S., Moore, D., Morales, S., Kumaran, A., Heller, R., Werlin, J., & Fortuna, K. L. (2026). Perspectives of People with Serious Mental Illness on Artificial Intelligence-Based Companions: “If no one told you I love you today, you have someone that cares for you.”. Community Mental Health Journal. https://doi.org/10.1007/s10597-026-01732-4

Image Credits: AI Generated

DOI: 10.1007/s10597-026-01732-4

Keywords: artificial intelligence, serious mental illness, AI companions, loneliness, schizophrenia, bipolar disorder, major depressive disorder, co-design, data privacy, digital mental health, qualitative research, supportive housing